MAM
Ormax releases research report on reality shows marketing
MUMBAI: The media and entertainment research and consulting firm Ormax Media has unveiled a special study on the effectiveness of marketing for the reality shows.
The nation-wide study is aimed at understanding ‘Reality Shows Marketing – Media Effectiveness’ for Hindi general entertainment channels (GECs).
The company used three big reality show launches of 2011 – Just Dance (Star Plus), Kaun Banega Crorepati (Sony Entertainment TV) and Bigg Boss 5 (Colors). The study analyses the impact of 13 different advertising and promotions media, in terms of their ability to create reach, buzz and appeal for reality shows.
Ormax Media CEO Shailesh Kapoor said: “In more than 20 years of satellite television in India, there has been no large-scale documented understanding of how each media should be used for program launches. This research will provide valuable information to the marketing departments at GECs, which will help them optimise their marketing spends, as well as understand the specific role of each medium in the overall media mix.”
The 13 media covered in the study were: self channel promos, cross channel promos, astons & bugs, news channel coverage, print ads, print articles, magazines, FM radio, out-of-home, theatre promotions, mall promotions, Internet promotions and word-of-mouth.
The study was conducted amongst more than 2400 Hindi GEC viewers in the 15-34 years age segment, across six cities.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
